Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
Journal for Immunotherapy of Cancer
|
October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Breast Cancer Research and Treatment
|
November 5, 2017
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain
Maryam B Lustberg, Tonya S Orchard, Raquel Reinbolt, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution
Briana To, Laura E Wright, Dureti Doto, et al.
Frontiers in Oncology
|
November 16, 2020
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Rahul Mal, Alexa Magner, Joel David, et al.
Psychoneuroendocrinology
|
January 22, 2026
Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients
Ángela Del Águila, Lindsay D Strehle, Seth Adarkwah Yiadom, et al.
Journal of Clinical Medicine
|
July 27, 2022
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
Michael Grimm, Lindsey Radcliff, Mariann Giles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2013
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy
Candice M Wenzell, Michael J Berger, Marlo A Blazer, et al.
The Oncologist
|
July 16, 2026
Impact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast Cancer
Andrea House, Julie A Stephens, Robert Wesolowski, et al.
Investigational New Drugs
|
January 16, 2020
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience
Anupama Suresh, Akannsha Ganju, Evan Morgan, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
Journal for Immunotherapy of Cancer
|
October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Breast Cancer Research and Treatment
|
November 5, 2017
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain
Maryam B Lustberg, Tonya S Orchard, Raquel Reinbolt, et al.
Breast Cancer Research : BCR
|
November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
May 4, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution
Briana To, Laura E Wright, Dureti Doto, et al.
Frontiers in Oncology
|
November 16, 2020
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Rahul Mal, Alexa Magner, Joel David, et al.
Psychoneuroendocrinology
|
January 22, 2026
Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients
Ángela Del Águila, Lindsay D Strehle, Seth Adarkwah Yiadom, et al.
Journal of Clinical Medicine
|
July 27, 2022
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
Michael Grimm, Lindsey Radcliff, Mariann Giles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2013
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy
Candice M Wenzell, Michael J Berger, Marlo A Blazer, et al.
The Oncologist
|
July 16, 2026
Impact of Oncotype DX Risk Categorization and Receipt of Chemotherapy on Survival Outcomes Among Patients with Small Node-Negative HR+ Breast Cancer
Andrea House, Julie A Stephens, Robert Wesolowski, et al.
Investigational New Drugs
|
January 16, 2020
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience
Anupama Suresh, Akannsha Ganju, Evan Morgan, et al.
Page
of 14